Petz Park

    Milk Thistle (Silymarin)

    Milk Thistle (Silybum marianum) is a flowering plant native to the Mediterranean region. Its seeds contain a group of active compounds collectively known as silymarin, with silybin being the most potent. Milk Thistle is the most widely studied natural ingredient for liver support in both human and veterinary medicine.

    Mechanism of Action

    Silymarin has several documented mechanisms of hepatoprotective action. It acts as a free radical scavenger, reducing oxidative damage to liver cells. It inhibits inflammatory signalling pathways, reducing hepatic inflammation. It has antifibrotic properties, reducing the production of collagen that leads to liver fibrosis (scarring). It promotes hepatocyte regeneration by stimulating ribosomal RNA synthesis in liver cells, supporting the liver's ability to repair damaged tissue. It also modifies bile composition in a way that reduces hepatotoxicity.

    Evidence Summary

    Silymarin has been studied in dogs and cats in both experimental and clinical settings. A 2013 review in the Journal of Veterinary Internal Medicine concluded that silymarin has hepatoprotective properties that are well established in animal models and has been used successfully in canine hepatopathies. It is one of the few natural supplements that veterinary hepatologists actively recommend. The evidence in cats is less extensive but the same mechanisms apply and veterinary use is common. Petz Park Liver Support for Dogs provides 190mg of Milk Thistle per scoop, equating to approximately 57mg silybin. Petz Park Liver Support for Cats provides 40mg per scoop, equating to approximately 12mg silybin.

    In Petz Park Products

    Liver Support for Dogs: Milk Thistle 190mg per scoop. Liver Support for Cats: Milk Thistle Extract 40mg per scoop.

    Safety and Considerations

    Milk Thistle is considered safe for dogs and cats at recommended doses. It has a well-established safety record in veterinary medicine. It may have mild laxative effects at high doses. Animals on immunosuppressive medications or anticoagulants should be monitored, as silymarin has theoretical interactions with these drug classes at pharmacological doses. At supplemental doses the risk is low but veterinary oversight is recommended in animals with diagnosed liver disease.

    Related Products

    Related Health Concerns

    Back to Ingredients